{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-037739","form_type":"8-K","ticker":"CODX","cik":"0001692415","company_name":"Co-Diagnostics, Inc.","filed_at":"2026-08-13T20:03:21+00:00","discovered_at":"2026-08-13T20:04:00.065226+00:00","generated_at":"2026-08-13T20:04:07.666475+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Co-Diagnostics Q2 net loss narrows to $6.3M; FDA 510(k) submitted for Flu/RSV test","bullets":["Revenue $0.17M vs $0.16M YoY; net loss $6.3M ($1.46/share) vs $7.7M ($7.00) prior year.","Operating loss $6.2M, improved from $8.1M; adjusted EBITDA loss $5.8M vs $7.2M; cash $3.6M.","Submitted FDA 510(k) for Flu A/B & RSV test on PCR Pro; clinical study 1,400+ patients, 27 analytical studies, 10,000+ runs.","Advanced Saudi manufacturing: industrial site approval and lease in Sudair Industrial City; distribution agreement in Mexico.","Appointed Wes Lindsey, Ph.D. as Chief Scientific Officer; initiated TB studies in India via CoSara."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-037739","json":"https://secwatch.observer/filing/0001493152-26-037739.json","markdown":"https://secwatch.observer/filing/0001493152-26-037739.md","text":"https://secwatch.observer/filing/0001493152-26-037739.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1692415/000149315226037739/0001493152-26-037739-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1692415/000149315226037739/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-13T20:04:07.666475+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}